Last reviewed · How we verify
NCT05288465
Hair Repigmentation During Cerebrolysin Therapy
NA trial testing Cerebrolysin in Hair Problems in 5 participants. Completed in 23 December 2016.
7 December 2015
Quick facts
| Lead sponsor | Universidad Autonoma de Nuevo Leon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 5 |
| Start date | 2 June 2014 |
| Primary completion | 7 December 2015 |
| Estimated completion | 23 December 2016 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Cerebrolysin — full drug profile →
Conditions studied
- Hair Problems — all drugs for Hair Problems →
Sponsor
Universidad Autonoma de Nuevo Leon — full company profile →
Who can join
40 and older, any sex, with Hair Problems. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes of follicular repigmentation that occurs during the Cerebrolysin treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation.
Villarreal-Reyna G, Garza-Morales R, Soto-Domínguez A, Montañez-Guerrero L, et al · · 2022 · cited 2× · PMID 36411485 · DOI 10.1186/s40001-022-00889-4
Verify or expand the search:
- PubMed search for NCT05288465
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cerebrolysin
Trials testing the same drug.
- NCT06339411 — Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights · EARLY_PHASE1 · not yet recruiting
- NCT06677502 — Cerebrolysin in Critically Ill Patients With Delirium · NA · enrolling by invitation
- NCT05755997 — CERebrolysin In CADASIL · Phase 2 · active not recruiting
- NCT06070753 — A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Str · NA · unknown
- NCT06052787 — Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU · Phase 3 · completed
Other Universidad Autonoma de Nuevo Leon trials
Trials by the same sponsor.
- NCT07449000 — Losartan for Corneal Fibrosis · NA · recruiting
- NCT07497555 — Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-G · NA · recruiting
- NCT06824922 — "Educational Intervention 'Be Yourself': Digital Innovation to Prevent Teenage Pregnancy" · NA · not yet recruiting
- NCT06861478 — PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease · Phase 2 · recruiting
- NCT06617299 — Cognitive-behavioral Intervention to Increase the Practice of Responsive Feeding and Maintain Healthy Weight in Infants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05288465 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Nuevo Leon
- Last refreshed: 21 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05288465.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing